Search - tctmd.com

Displaying 141 - 160 of 299

Sort: Relevancy | Date

Presentation TCT 2017

The PARTNER 3 Low-risk Trial

Presenter: Michael J. Mack

October 30, 2017

Presentation TCT 2017

Viewpoint #2: Not So Fast! GARY and Other Studies Indicate an Important Role for Surgery in Intermediate-risk Patients

Presenter: Thomas Walther

October 30, 2017

Presentation TCT 2017

Viewpoint #1: PARTNER 2A and SURTAVI are Convincing TAVR is Preferred in ALL (Appropriate) Intermediate-Risk Patients

Presenter: Michael J. Reardon

October 30, 2017

Presentation TCT 2017

MitraClip For the Low and Intermediate Risk Degenerative MR Patient: Ethics and Outcomes

Presenter: Ted Feldman, Scott Lim, James B. Hermiller Jr.

October 30, 2017

Presentation TCT 2017

Case Presentation: Mitraclip in a Low to Intermediate Surgical Risk Patient With Degenerative MR

Presenter: Ted Feldman, Scott Lim, Michael J. Rinaldi

October 30, 2017

Presentation TCT 2017

Conclusions and Take-home Messages

Presenter: Dariusz Dudek, Martin Hudec

October 30, 2017

Presentation TCT 2017

Germany Presents: Case Conclusion - How I Treated This Case

Presenter: Dariusz Dudek, Martin Hudec, Julia Seeger

October 30, 2017

Presentation TCT 2017

Slovakia Comments: How Would I Treat This Case?

Presenter: Dariusz Dudek, Martin Hudec, Branislav Liska

October 30, 2017

Presentation TCT 2017

Germany Presents: Case Introduction - TAVR in a Low-Risk Patient With Cerebral Embolic Protection

Presenter: Dariusz Dudek, Martin Hudec, Julia Seeger

October 30, 2017

Presentation TCT 2017

Czech Republic Presents: Case Conclusion - How I Treated This Case

Presenter: Dariusz Dudek, Martin Hudec, Marian Branny

October 30, 2017

Presentation TCT 2017

Poland Comments: How Would I Treat This Case?

Presenter: Dariusz Dudek, Martin Hudec, Wojtek Wojakowski

October 30, 2017

Presentation TCT 2017

Czech Republic Presents: Case Introduction - Severe Aortic Stenosis in a Low-Risk Patient

Presenter: Dariusz Dudek, Martin Hudec, Marian Branny

October 30, 2017

Presentation TCT 2017

Germany Presents: Future Perspective - TAVR Compared to Surgical Valve Replacement in Patients With Low-Risk Scores Potential Benefits and Harms

Presenter: Dariusz Dudek, Martin Hudec, Michael Haude

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing LOW RISK TAVR Trials Change How We Treat Low Surgical Risk Patients With Aortic Stenosis?

Presenter: David H. Adams, Ted Feldman, Craig R. Smith

October 30, 2017

Presentation TCT 2017

Were ready to treat bicuspid valve and lower-risk tricuspid valve aortic stenosis!

Presenter: Susheel K. Kodali

October 30, 2017

Presentation TCT 2017

TAVR in Low-Risk Patients

Presenter: Jeroen J. Bax, Axel Linke, Thomas Pilgrim

October 29, 2017

Presentation TVT 2017

SURTAVI Vignette II: Subset Analysis of Patients With STS < 3% (Lower-Risk Patients)

Presenter: David J. Cohen, Jeffrey J. Popma

June 16, 2017

Presentation TVT 2017

A Primer on Surgical Concepts of Structural Valve Deterioration and Guidelines for New Surgical Bioprosthetic Valves Implications for TAVR

Presenter: A. Pieter Kappetein

June 15, 2017

Presentation TVT 2017

Incidence, Predictors, and Consequences of Permanent Pacemakers after TAVR

Presenter: Tamim Nazif

June 15, 2017

Presentation TVT 2017

How to Optimize TAVR Device Placement to Reduce the Frequency of Conduction Abnormalities

Presenter: Nicolo Piazza

June 15, 2017

Advertisement

The PARTNER 3 Low-risk Trial

Viewpoint #2: Not So Fast! GARY and Other Studies Indicate an Important Role for Surgery in Intermediate-risk Patients

Viewpoint #1: PARTNER 2A and SURTAVI are Convincing TAVR is Preferred in ALL (Appropriate) Intermediate-Risk Patients

MitraClip For the Low and Intermediate Risk Degenerative MR Patient: Ethics and Outcomes

Case Presentation: Mitraclip in a Low to Intermediate Surgical Risk Patient With Degenerative MR

Conclusions and Take-home Messages

Germany Presents: Case Conclusion - How I Treated This Case

Slovakia Comments: How Would I Treat This Case?

Germany Presents: Case Introduction - TAVR in a Low-Risk Patient With Cerebral Embolic Protection

Czech Republic Presents: Case Conclusion - How I Treated This Case

Poland Comments: How Would I Treat This Case?

Czech Republic Presents: Case Introduction - Severe Aortic Stenosis in a Low-Risk Patient

Germany Presents: Future Perspective - TAVR Compared to Surgical Valve Replacement in Patients With Low-Risk Scores Potential Benefits and Harms

Predicting the Future: Will the Ongoing LOW RISK TAVR Trials Change How We Treat Low Surgical Risk Patients With Aortic Stenosis?

Were ready to treat bicuspid valve and lower-risk tricuspid valve aortic stenosis!

TAVR in Low-Risk Patients

SURTAVI Vignette II: Subset Analysis of Patients With STS < 3% (Lower-Risk Patients)

A Primer on Surgical Concepts of Structural Valve Deterioration and Guidelines for New Surgical Bioprosthetic Valves Implications for TAVR

Incidence, Predictors, and Consequences of Permanent Pacemakers after TAVR

How to Optimize TAVR Device Placement to Reduce the Frequency of Conduction Abnormalities

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content